ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,733,845, issued on Sept. 15, was assigned to Willow Laboratories Inc. (Irvine, Calif.).
"Implantable micro-electrochemical cell" was invented by Venkatramanan Krishnamani (Irvine, Calif.) and Anando Devadoss (Irvine, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A disease management system including an microelectrochemical cell configured to be implanted into a patient. The microelectrochemical cell may include a tube which may include at least one sidewall, a closed end configured to be implanted in the patient, and open end configured to receive a feedthrough for at least one electrode lead. The microelectrochemical cell may further include a...